<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2024.1399511</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Variants of <italic>SLC39A4</italic> cause acrodermatitis enteropathica in Tibetan, Yi, and Han families in Sichuan region of southwestern China: a case report series</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Zhongtao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2664721/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wang</surname> <given-names>Sheng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2708260/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Dermatology, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Devinder Mohan Thappa, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Arti Nanda, As'ad Al-Hamad Dermatology Center, Kuwait</p>
<p>Leila Youssefian, University of California, Los Angeles, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Sheng Wang, <email>wangsheng1892@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1399511</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Li and Wang.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Li and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Acrodermatitis enteropathica (AE, OMIM 201100) is a rare autosomal recessive dermatosis characterized by periorificial dermatitis, diarrhea, alopecia, and hypozincaemia due to pathogenic variants of <italic>SLC39A4</italic>. Herein, we present a case series describing four unrelated patients with AE from Han, Yi, and Tibetan ethnicities in Sichuan region of southwestern China, speculate the hotspot variants of <italic>SLC39A4</italic> causing AE in Sichuan region and highlight physicians should be alerted to unusual presentations of AE, such as the absence of hypozincaemia and the presence of acne-like lesions. Serum alkaline phosphatase and genetic testing should be considered to accurately evaluate the zinc deficiency in human body and help make the correct diagnosis.</p>
</abstract>
<kwd-group>
<kwd>acrodermatitis enteropathica</kwd>
<kwd>normal serum zinc</kwd>
<kwd>pustule</kwd>
<kwd>Tibetan</kwd>
<kwd><italic>SLC39A4</italic></kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="12"/>
<page-count count="6"/>
<word-count count="2873"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Dermatology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Acrodermatitis enteropathica (AE, OMIM 201100) is a rare autosomal recessive skin disease characterized by periorificial dermatitis, diarrhea, and alopecia. It is usually associated with hypozincaemia due to the defect in ZIP4 zinc transporter encoded by <italic>SLC39A4</italic>. Two Tibetan patients with AE from Sichuan region of southwestern China had been previously reported by our group (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>). Herein, we added another four patients from Han, Yi, and Tibetan families in Sichuan region and reported the unusual presentations in AE.</p>
</sec>
<sec id="sec2">
<label>2</label>
<title>Case reports</title>
<sec id="sec3">
<label>2.1</label>
<title>Case 1</title>
<p>An 18-year-old man, born to non-consanguineous, healthy Han parents, presented with papules and pustules on the face and extremities since the age of 4 years. Physical examination revealed erythema, papules, pustules, crusts and scars on the face, trunk and periorificial region (<xref ref-type="fig" rid="fig1">Figures 1A</xref>,<xref ref-type="fig" rid="fig1">B</xref>). Diarrhea and hair loss were absent. He was repeatedly diagnosed with &#x201C;acne&#x201D; in local hospitals, but the anti-acne treatment with minocycline achieved no improvement. The serum zinc level was 103.8&#x2009;&#x03BC;mol/L (normal 76.5&#x2013;170.0&#x2009;&#x03BC;mol/L), while the serum alkaline phosphatase level was only 41&#x2009;IU/L (lower than the normal range of 45&#x2013;125&#x2009;IU/L). Sanger sequencing was performed using the genomic DNA of the patient and his parents. The patient was found to carry a 24-bp heterozygous deletion in exon 9 and intron 9 (c.1452_1474&#x2009;+&#x2009;1del TGAGCCCAGGAGACTGAGCCCAGG) and a heterozygous splicing variant in intron 7 (c.1288-1G&#x2009;&#x003E;&#x2009;A) of <italic>SLC39A4</italic> (RefSeq NM_130849.4). His father and mother were found to be heterozygous for c.1452_1474&#x2009;+&#x2009;1del TGAGCCCAGGAGACTGAGCCCAGG and c.1288-1G&#x2009;&#x003E;&#x2009;A, respectively (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Thus, the diagnosis of AE was established. After 7&#x2009;weeks of continuous treatment with a single oral zinc sulfate (50&#x2009;mg three times daily), his skin lesions almost completely disappeared (<xref ref-type="fig" rid="fig1">Figures 1D</xref>,<xref ref-type="fig" rid="fig1">E</xref>) and the serum level of alkaline phosphatase increased to 90&#x2009;IU/L.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Clinical manifestations and variants of <italic>SLC39A4</italic> in patient 1 with AE. <bold>(A,B)</bold> Generalized pustules on the face and trunk prior to the treatment. <bold>(C)</bold> Heterozygous deletion of TGAGCCCAGGAGACTGAGCCCAGG in exon 9 and the adjoining intron 9 in patient 1 and his father. Heterozygous splicing variant c.1288-1G&#x2009;&#x003E;&#x2009;A in intron 7 in patient 1 and his mother. <bold>(D,E)</bold> Marked relief of the lesions after 7&#x2009;weeks of zinc supplementation.</p>
</caption>
<graphic xlink:href="fmed-11-1399511-g001.tif"/>
</fig>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Case 2</title>
<p>The patient was a girl aged 1&#x2009;year and 10&#x2009;months, the fourth child of second-degree consanguineous parents with Yi ethnicity (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; IV: 4). Her parents reported erythema and crusts appeared on her periorificial areas accompanied with alopecia and chronic diarrhea since 4&#x2009;months after birth. Her older brother had a history of similar lesions and alopecia, but had already died at the age of 3&#x2009;years (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; IV: 3). Physical examination revealed well-demarcated erythema and crusts on her hands, feet, extensor surface of the knees and in the perioral, periocular, perigenital, and perianal regions (<xref ref-type="fig" rid="fig2">Figures 2B</xref>&#x2013;<xref ref-type="fig" rid="fig2">D</xref>). Her serum zinc level was 0.13&#x2009;mg/L (normal 0.76&#x2013;1.50&#x2009;mg/L) and the serum alkaline phosphatase level was only 22&#x2009;IU/L (normal 128&#x2013;432&#x2009;IU/L). Sanger sequencing analysis showed the patient carried a homozygous c.295G&#x2009;&#x003E;&#x2009;A (p.Ala99Thr) in exon 2 of <italic>SLC39A4</italic> (RefSeq NM_130849.4) (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Considering the diagnosis of AE, zinc supplementation at 3&#x2009;mg per kg-body-weight was started, which led to complete remission after 2&#x2009;weeks.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Clinical findings and the variant of <italic>SLC39A4</italic> in patient 2 with AE. <bold>(A)</bold> Pedigree of the Chinese Yi family of patient 2. <bold>(B&#x2013;D)</bold> Erythema and crusted lesions in the periorificial region and extensor surface of the knees. <bold>(E)</bold> Homozygous missense variant of c.295G&#x2009;&#x003E;&#x2009;A in exon 2 of patient 2 and heterozygous variant for her parents.</p>
</caption>
<graphic xlink:href="fmed-11-1399511-g002.tif"/>
</fig>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>Case 3</title>
<p>An 8-month-old Tibetan boy was referred to our department for evaluation of exanthema on the face and anogenital regions, which had developed approximately 4&#x2009;months after birth. He had diarrhea, hair loss and irritability. There was no history of any consanguineous marriage in the family. Examination revealed well-demarcated erythema and crusts on the neck, flexor side of the lower extremities and in the perioral, periocular, perigenital, and perianal regions (<xref ref-type="fig" rid="fig3">Figures 3A</xref>,<xref ref-type="fig" rid="fig3">B</xref>). Laboratory data were within normal limits except for reduced serum zinc 28.44&#x2009;&#x03BC;mol/L (normal 33.5&#x2013;84.54&#x2009;&#x03BC;mol/L). The detection of serum alkaline phosphatase was not performed. Sanger sequencing of <italic>SLC39A4</italic> (RefSeq NM_130849.4) revealed that the patient was compound heterozygous for maternal c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG in exon 9 and intron 9 and paternal c.1110insG in exon 6 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Both variants have been reported to be pathogenic (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref3">3</xref>). The patient showed marked improvement after 2&#x2009;weeks of oral zinc supplements.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p><bold>(A,B)</bold> Clinical findings of patient 3 showed well-demarcated erythema and crusted lesions in the neck, feet, periorificial region, and flexor surface of the lower legs. <bold>(C)</bold> Heterozygous deletion of AGACTGAGCCCAGG in exon 9 and the adjoining intron 9 of <italic>SLC39A4</italic> in patient 3 and his mother. Heterozygous frame-shift variant of c.1110insG in exon 6 of <italic>SLC39A4</italic> in patient 3 and his father. <bold>(D)</bold> Homozygous frame-shift variant of c.1110insG in exon 6 of <italic>SLC39A4</italic> in patient 4.</p>
</caption>
<graphic xlink:href="fmed-11-1399511-g003.tif"/>
</fig>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Case 4</title>
<p>A 10-year-old Tibetan girl presented with eczematous lesions in the perioral, perigenital, and perianal regions accompanied with diarrhea since 7&#x2009;months after weaning. No alopecia was observed. She had been diagnosed with AE and the skin lesions had been almost disappeared with oral zinc supplements when she came to our department. The patient&#x2019;s serum zinc level and serum alkaline phosphatase were not detected. No consanguinity was reported in the family. Sanger sequencing of all exons and their flanking intronic regions of <italic>SLC39A4</italic> (RefSeq NM_130849.4) identified a homozygous c.1110insG variant in the patient (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec7">
<label>3</label>
<title>Discussion</title>
<p><italic>SLC39A4</italic> have been found to be responsible for the development of AE (<xref ref-type="bibr" rid="ref1">1</xref>). Pathogenic variants of <italic>SLC39A4</italic> would impair the zinc absorption of the ZIP4 transporter in the small intestine, leading to the zinc deficiency, further resulting in various clinical manifestations, such as skin dermatitis, alopecia, diarrhea, growth retardation, and neuropsychiatric symptoms (<xref ref-type="bibr" rid="ref4">4</xref>). To date, 14 cases with <italic>SLC39A4</italic> variants have been found in AE patients from China in the literature, including four cases described here (<xref ref-type="table" rid="tab1">Table 1</xref>) (<xref ref-type="bibr" rid="ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10">1&#x2013;10</xref>). Among them, more than half (<italic>n</italic>&#x2009;=&#x2009;8, 57.14%) were from Sichuan region of southwestern China, indicating it may be one of the high AE incidence areas. In addition, not all of them simultaneously have the classic triad of skin dermatitis, alopecia, and diarrhea. Growth retardation and neuropsychiatric symptoms were found in a few patients with AE.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Summary of cases of AE with the <italic>SLC39A4</italic> variant from China.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Case</th>
<th align="center" valign="top" rowspan="2">Year</th>
<th align="left" valign="top" rowspan="2">Authors</th>
<th align="left" valign="top" rowspan="2">Sex</th>
<th align="left" valign="top" rowspan="2">Age of onset</th>
<th align="left" valign="top" rowspan="2">Origin</th>
<th align="left" valign="top" rowspan="2">History of consanguinity</th>
<th align="left" valign="top" rowspan="2">Family members have similar symptoms</th>
<th align="left" valign="top" colspan="4">Clinical manifestations</th>
<th align="left" valign="top" rowspan="2">Serum zinc level</th>
<th align="left" valign="top" rowspan="2">Serum alkaline phosphatase level</th>
<th align="left" valign="top" rowspan="2"><italic>SLC39A4</italic> variants</th>
</tr>
<tr>
<th align="left" valign="top">Skin lesions</th>
<th align="left" valign="top">Alopecia</th>
<th align="left" valign="top">Diarrhea</th>
<th align="left" valign="top">Other symptoms</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="center" valign="top">2008</td>
<td align="left" valign="top">Wang et al. (<xref ref-type="bibr" rid="ref1">1</xref>)</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">3&#x2009;months</td>
<td align="left" valign="top">Sichuan (Tibetan)</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Older brother</td>
<td align="left" valign="top">Atypical (generalized pustules)</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Homozygous for c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG (exon 9 and intron 9)</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="center" valign="top">2010</td>
<td align="left" valign="top">Li et al. (<xref ref-type="bibr" rid="ref5">5</xref>)</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">5&#x2009;months</td>
<td align="left" valign="top">Jiangsu</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Homozygous for c.1115&#x2009;T&#x2009;&#x003E;&#x2009;G (exon 6)</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="center" valign="top">2014</td>
<td align="left" valign="top">Gao et al. (<xref ref-type="bibr" rid="ref6">6</xref>)</td>
<td align="left" valign="top">M</td>
<td align="left" valign="top">Infancy</td>
<td align="left" valign="top">Jiangsu</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Growth retardation</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Compound heterozygous for c.831G&#x2009;&#x003E;&#x2009;A (exon 5) and c.1617delA (exon10)</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="center" valign="top">2016</td>
<td align="left" valign="top">Zhou et al. (<xref ref-type="bibr" rid="ref2">2</xref>)</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">Several months after birth</td>
<td align="left" valign="top">Sichuan (Tibetan)</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Older brother and sister</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Homozygous for c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG (exon 9 and intron 9)</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="center" valign="top">2017</td>
<td align="left" valign="top">Mou et al. (<xref ref-type="bibr" rid="ref3">3</xref>)</td>
<td align="left" valign="top">M</td>
<td align="left" valign="top">Several days after birth</td>
<td align="left" valign="top">Sichuan (Han)</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Anorexia, apathia</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Compound heterozygous for c.1110InsG (exon 6) and c.958C&#x2009;&#x003E;&#x2009;T (exon 5)</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="center" valign="top">2019</td>
<td align="left" valign="top">Wu et al. (<xref ref-type="bibr" rid="ref7">7</xref>)</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">2&#x2009;months</td>
<td align="left" valign="top">Guangdong</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Two brothers and two sisters</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Normal</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Homozygous for c.106C&#x2009;&#x003E;&#x2009;T (exon 1)</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Zhou et al. (<xref ref-type="bibr" rid="ref8">8</xref>)</td>
<td align="left" valign="top">M</td>
<td align="left" valign="top">3&#x2009;days</td>
<td align="left" valign="top">Guangdong</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Homozygous for c.948delC (exon 5)</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Zhong et al. (<xref ref-type="bibr" rid="ref4">4</xref>)</td>
<td align="left" valign="top">M</td>
<td align="left" valign="top">12&#x2009;months</td>
<td align="left" valign="top">Guangdong</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Twin brother</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Apathia</td>
<td align="left" valign="top">Normal</td>
<td align="left" valign="top">Normal</td>
<td align="left" valign="top">Compound heterozygous for c.926G&#x2009;&#x003E;&#x2009;T (exon 5) and c.976&#x2009;+&#x2009;2&#x2009;T&#x2009;&#x003E;&#x2009;A (intron 5)</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">Li et al. (<xref ref-type="bibr" rid="ref9">9</xref>)</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">3&#x2009;months</td>
<td align="left" valign="top">Hunan</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Younger brother</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Normal</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Homozygous for c.1456delG (exon9)</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">Hua et al. (<xref ref-type="bibr" rid="ref10">10</xref>)</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">1&#x2009;year</td>
<td align="left" valign="top">Sichuan (Han)</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Compound heterozygous for c.1466dupT (exon 9) and c.295G&#x2009;&#x003E;&#x2009;A (exon 2)</td>
</tr>
<tr>
<td align="left" valign="top">11</td>
<td align="center" valign="top">2024</td>
<td align="left" valign="top">Present patient 1</td>
<td align="left" valign="top">M</td>
<td align="left" valign="top">4&#x2009;years</td>
<td align="left" valign="top">Sichuan (Han)</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Atypical (acne-like pustules)</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Normal</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Compound heterozygous for c.1452_1474&#x2009;+&#x2009;1del TGAGCCCAGGAGACTGAGCCCAGG (exon 9 and intron 9) and c.1288-1G&#x2009;&#x003E;&#x2009;A (intron 7)</td>
</tr>
<tr>
<td align="left" valign="top">12</td>
<td align="center" valign="top">2024</td>
<td align="left" valign="top">Present patient 2</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">4&#x2009;months</td>
<td align="left" valign="top">Sichuan (Yi)</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Older brother</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Homozygous for c.295G&#x2009;&#x003E;&#x2009;A (exon 2)</td>
</tr>
<tr>
<td align="left" valign="top">13</td>
<td align="center" valign="top">2024</td>
<td align="left" valign="top">Present patient 3</td>
<td align="left" valign="top">M</td>
<td align="left" valign="top">4&#x2009;months</td>
<td align="left" valign="top">Sichuan (Tibetan)</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">Irritability</td>
<td align="left" valign="top">Low</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Compound heterozygous for c.1462_1474&#x2009;+&#x2009;1delAGACTGAGCCCAGG (exon 9 and intron 9) and c.1110insG (exon 6)</td>
</tr>
<tr>
<td align="left" valign="top">14</td>
<td align="center" valign="top">2024</td>
<td align="left" valign="top">Present patient 4</td>
<td align="left" valign="top">F</td>
<td align="left" valign="top">7&#x2009;months</td>
<td align="left" valign="top">Sichuan (Tibetan)</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Typical</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Yes</td>
<td align="left" valign="top">No</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Not detected</td>
<td align="left" valign="top">Homozygous for c.1110insG (exon 6)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>AE, Acrodermatitis enteropathica; F, Female; M, Male.</p>
</table-wrap-foot>
</table-wrap>
<p>A total of 15 <italic>SLC39A4</italic> variants have been reported in AE patients from China, almost half of which, seven variants, were found in Sichuan region (<xref ref-type="table" rid="tab1">Table 1</xref>). Unlike other areas, some variants, including c.295G&#x2009;&#x003E;&#x2009;A, c.1110insG and c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG, were repeatedly identified in Sichuan region. In particular, the c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG variant was exclusively identified in Tibetan ethnicity. Given the enclosed environment and prevalence of consanguineous marriage in this region, besides hotspot variants, we consider the founder effect is likely to exist.</p>
<p>Acrodermatitis enteropathica is typically manifested by periorificial dermatitis and usually associated with hypozincaemia. However, a few patients could exhibit some atypical lesions, such as generalized pustules and blisters mimicking infectious diseases, or plaques resembling psoriasis and palmoplantar keratoderma (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>). Moreover, serum zinc level could be normal in a minority of patients with AE (<xref ref-type="bibr" rid="ref7">7</xref>). As in this study, the skin lesions of patient 1 presented with erythema, papules, pustules, and scars on the face and trunk, which were so much like acne. In addition, his serum zinc level was normal but the serum alkaline phosphatase level was low. The acne-like lesions improved obviously and serum alkaline phosphatase level increased to the normal range after administration with a single regimen of zinc sulfate. Under this condition, patients with low serum alkaline phosphatase level presenting acne-like lesions should raise a high suspicious of atypical AE. Detection of zinc-dependent metalloenzyme serum alkaline phosphatase, a more sensitive and precise parameter for the assessment of zinc deficiency, is very essential to help make a correct diagnosis.</p>
</sec>
<sec sec-type="conclusions" id="sec8">
<label>4</label>
<title>Conclusion</title>
<p>Overall, in this study, a total of five variants of <italic>SLC39A4</italic>, including two unreported before, was identified in four unrelated patients with AE from three different ethnicities in Sichuan region of southwestern China. The three recurrent variants, c.295G&#x2009;&#x003E;&#x2009;A, c.1110insG, and c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG, seem to be hotspot variants of <italic>SLC39A4</italic> in patients with AE from Sichuan region. Of note, the c.1462_1474&#x2009;+&#x2009;1del AGACTGAGCCCAGG variant was exclusively identified in Tibetan ethnicity, implying a founder effect is likely to exist. Sichuan region of southwestern China may be one of the high AE incidence areas. Unusual acne-like lesions developed in a Han patient with a normal serum zinc level, which highlights the diversity of clinical manifestations of AE. Serum alkaline phosphatase and genetic tests are necessary for evaluating the zinc deficiency in human body and helping make the correct diagnosis. In this study, some limitations should not be neglected, especially the small sample size. Therefore, more works are needed to verify our findings based on larger sample size in the future.</p>
</sec>
<sec sec-type="data-availability" id="sec9">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec10">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the ethics committee of West China Hospital, Sichuan University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin. Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec sec-type="author-contributions" id="sec11">
<title>Author contributions</title>
<p>ZL: Data curation, Formal Analysis, Methodology, Writing &#x2013; original draft. SW: Conceptualization, Resources, Supervision, Validation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec12">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>We acknowledge the patients and their families.</p>
</ack>
<sec sec-type="COI-statement" id="sec13">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec14">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec15">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2024.1399511/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmed.2024.1399511/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Xue</surname> <given-names>L</given-names></name> <name><surname>Guo</surname> <given-names>ZP</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name></person-group>. <article-title>A novel SLC39A4 gene mutation in the family of an acrodermatitis enteropathica patient with an unusual presentation</article-title>. <source>Br J Dermatol</source>. (<year>2008</year>) <volume>159</volume>:<fpage>976</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2133.2008.08777.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18684156</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>XY</given-names></name> <name><surname>Chen</surname> <given-names>XJ</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Xue</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>W</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name> <etal/></person-group>. <article-title>One recurrent homozygous mutation of SLC39A4 in a girl with acrodermatitis enteropathica from southwestern China</article-title>. <source>Int J Dermatol</source>. (<year>2016</year>) <volume>55</volume>:<fpage>223</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ijd.12442</pub-id>, PMID: <pub-id pub-id-type="pmid">24962159</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>Z</given-names></name> <name><surname>Yang</surname> <given-names>P</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Analysis of SLC39A4 gene mutation in a patient with acrodermatitis enteropathica</article-title>. <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>. (<year>2017</year>) <volume>34</volume>:<fpage>387</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.3760/cma.j.issn.1003-9406.2017.03.016</pub-id>, PMID: <pub-id pub-id-type="pmid">28604961</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>W</given-names></name> <name><surname>Yang</surname> <given-names>C</given-names></name> <name><surname>Zhu</surname> <given-names>L</given-names></name> <name><surname>Huang</surname> <given-names>YQ</given-names></name> <name><surname>Chen</surname> <given-names>YF</given-names></name></person-group>. <article-title>Analysis of the relationship between the mutation site of the SLC39A4 gene and acrodermatitis enteropathica by reporting a rare Chinese twin: a case report and review of the literature</article-title>. <source>BMC Pediatr</source>. (<year>2020</year>) <volume>20</volume>:<fpage>34</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12887-020-1942-4</pub-id>, PMID: <pub-id pub-id-type="pmid">31987033</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>CR</given-names></name> <name><surname>Yan</surname> <given-names>SM</given-names></name> <name><surname>Shen</surname> <given-names>DB</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name> <name><surname>Shao</surname> <given-names>JP</given-names></name> <name><surname>Xue</surname> <given-names>CY</given-names></name> <etal/></person-group>. <article-title>One novel homozygous mutation of SLC39A4 gene in a Chinese patient with acrodermatitis enteropathica</article-title>. <source>Arch Dermatol Res</source>. (<year>2010</year>) <volume>302</volume>:<fpage>315</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00403-010-1047-2</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>S</given-names></name> <name><surname>You</surname> <given-names>SH</given-names></name> <name><surname>Fan</surname> <given-names>ZN</given-names></name></person-group>. <article-title>A study of SLC39A4 gene mutation responsible for acrodermatitis enteropathica</article-title>. <source>Acta Univ Med Nanjing</source>. (<year>2014</year>) <volume>34</volume>:<fpage>660</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.7655/NYDXBNS20140525</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>F</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>X</given-names></name> <name><surname>Lu</surname> <given-names>P</given-names></name> <name><surname>Yang</surname> <given-names>C</given-names></name> <name><surname>Man</surname> <given-names>MQ</given-names></name> <etal/></person-group>. <article-title>Novel nonsense mutation of the SLC39A4 gene in a family with atypical acrodermatitis enteropathica</article-title>. <source>Clin Exp Dermatol</source>. (<year>2019</year>) <volume>44</volume>:<fpage>933</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ced.13964</pub-id>, PMID: <pub-id pub-id-type="pmid">30980548</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Xue</surname> <given-names>R</given-names></name> <name><surname>Luo</surname> <given-names>Q</given-names></name> <name><surname>Zhang</surname> <given-names>SQ</given-names></name></person-group>. <article-title>A study of SLC39A4 gene mutation in acrodermatitis enteropathica</article-title>. <source>Chin J Dermatovenereol</source>. (<year>2020</year>) <volume>34</volume>:<fpage>739</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.13735/j.cjdv.1001-7089.201909054</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>KY</given-names></name> <name><surname>Tang</surname> <given-names>JP</given-names></name> <name><surname>Shu</surname> <given-names>Y</given-names></name> <name><surname>Qiu</surname> <given-names>SZ</given-names></name> <name><surname>Wang</surname> <given-names>YW</given-names></name> <name><surname>Wen</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Recurrent systemic sporadic rash for 10 years in a girl aged 11 years</article-title>. <source>Zhongguo Dang Dai Er Ke Za Zhi</source>. (<year>2022</year>) <volume>24</volume>:<fpage>1047</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2204123</pub-id>, PMID: <pub-id pub-id-type="pmid">36111725</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>W</given-names></name> <name><surname>Zou</surname> <given-names>J</given-names></name> <name><surname>Zhuang</surname> <given-names>Y</given-names></name> <name><surname>Zhou</surname> <given-names>T</given-names></name></person-group>. <article-title>Case report: Acrodermatitis enteropathica result from a novel SLC39A4 gene mutation</article-title>. <source>Front Pediatr</source>. (<year>2022</year>) <volume>10</volume>:<fpage>972030</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fped.2022.972030</pub-id>, PMID: <pub-id pub-id-type="pmid">36479285</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyengar</surname> <given-names>S</given-names></name> <name><surname>Chambers</surname> <given-names>C</given-names></name> <name><surname>Sharon</surname> <given-names>VR</given-names></name></person-group>. <article-title>Bullous acrodermatitis enteropathica: case report of a unique clinical presentation and review of the literature</article-title>. <source>Dermatol Online J</source>. (<year>2015</year>) <volume>21</volume>:<fpage>13030</fpage>. doi: <pub-id pub-id-type="doi">10.5070/D3214026272</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Behera</surname> <given-names>B</given-names></name> <name><surname>Mohapatra</surname> <given-names>L</given-names></name> <name><surname>Sahu</surname> <given-names>B</given-names></name> <name><surname>Patnaik</surname> <given-names>M</given-names></name></person-group>. <article-title>A case of acrodermatitis enteropathica mimicking mutilating palmoplantar keratoderma</article-title>. <source>Indian J Dermatol</source>. (<year>2022</year>) <volume>67</volume>:<fpage>314</fpage>. doi: <pub-id pub-id-type="doi">10.4103/ijd.IJD_112_17</pub-id></citation></ref>
</ref-list>
</back>
</article>